Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Clinical Trial of Ipratropium Bromide Spray as a Treatment for Sialorrhea in Patients With Parkinson's Disease

NCT00296946 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT00296946
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00296946 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Clinical Trial of Ipratropium Bromide Spray as a Treatment for Sialorrhea in Patients With Parkinson's Disease
Lead sponsor
University Health Network, Toronto
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2004
Completion date
June 30, 2006
Enrollment
20
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease